Multiple RCTs evaluating EVAR enabled pooling of data in quest for high-quality evidence

696

Roger Greenhalgh (London, UK), was honoured at the 2018 VEITHsymposium alongside other endovascular aneurysm repair (EVAR) pioneers. He spoke to Vascular News about his conviction in the late 1990s that prospective randomised controlled trials were the way to properly test EVAR, a new endovascular treatment option for abdominal aortic aneurysm patients, and how this served as a motivation to undertake the EVAR-1 trial.

 


LEAVE A REPLY

Please enter your comment!
Please enter your name here